Related Experiment Video
Updated: Apr 21, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11.1K
Current treatment options for non-small-cell lung cancer
Oncology (Williston Park, N.Y.)
|November 7, 2014
Summary
Systemic treatments for advanced non-small-cell lung cancer (NSCLC) are evolving. While chemotherapy remains key, targeted therapies and updated treatment strategies are improving outcomes for NSCLC patients.
Area of Science:
- Oncology
- Medical Oncology
Background:
- Non-small-cell lung cancer (NSCLC) presents significant treatment challenges, particularly in advanced stages, with limited durable survival rates.
- Platinum-based chemotherapy is the standard treatment but offers modest efficacy.
- Recent advancements necessitate a re-evaluation of treatment strategies.
Purpose of the Study:
- To review current systemic treatment modalities for non-small-cell lung cancer (NSCLC).
- To highlight recent changes in the NSCLC treatment paradigm.
Main Methods:
- Review of current clinical trial outcomes and treatment guidelines for NSCLC.
- Analysis of the impact of histology, mutation status, and biomarkers on treatment selection.
- Examination of evolving treatment strategies including targeted therapies and maintenance regimens.
Main Results:
- Treatment selection is increasingly influenced by molecular profiling (histology, mutations, biomarkers).
- Oral tyrosine kinase inhibitors and monoclonal antibodies are integral to current NSCLC treatment.
- Chemotherapy is being utilized earlier in disease management (neoadjuvant, adjuvant settings).
Conclusions:
- The NSCLC treatment landscape has shifted towards personalized medicine.
- Integration of targeted therapies and modified treatment schedules improves patient outcomes.
- Systemic therapy plays a crucial role across various stages of NSCLC management.
Related Concept Videos
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
02:57Targeted Cancer Therapies
1.8K
1.8K
02:49Cancer Therapies
10.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
673
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
673